110 related articles for article (PubMed ID: 627735)
41. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
Sanders WE; Sanders CC
J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
[No Abstract] [Full Text] [Related]
42. Sisomicin in surgical infections. Laboratory and clinical studies.
Perea EJ; Gutierrez de la Pena C; Oliver DA; Solorzano G; Garcia-Diaz S
Arzneimittelforschung; 1979; 29(1):134-7. PubMed ID: 375945
[TBL] [Abstract][Full Text] [Related]
43. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
[TBL] [Abstract][Full Text] [Related]
44. Combination effect with some aminoglycoside antibiotics.
Jedlicková Z; Rýc M; Libánská A
J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):204-6. PubMed ID: 6788839
[TBL] [Abstract][Full Text] [Related]
45. An electron microscopic study of the effect of clindamycin therapy on bacterial adherence and glycocalyx formation in experimental Staphylococcus aureus osteomyelitis.
Mayberry-Carson KJ; Tober-Meyer B; Lambe DW; Costerton JW
Microbios; 1986; 48(196-197):189-206. PubMed ID: 3796304
[TBL] [Abstract][Full Text] [Related]
46. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
[TBL] [Abstract][Full Text] [Related]
47. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
48. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
Daurel C; Prunier AL; Chau F; Garry L; Leclercq R; Fantin B
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):344-9. PubMed ID: 17714489
[TBL] [Abstract][Full Text] [Related]
49. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
[TBL] [Abstract][Full Text] [Related]
50. [Therapeutic efficacy of norfloxacin for experimental osteomyelitis in rabbits].
Okada J; Kaetsu M; Aijima H
Jpn J Antibiot; 1992 May; 45(5):502-6. PubMed ID: 1512935
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
[TBL] [Abstract][Full Text] [Related]
52. [Activity of indolicidin, alone or together with oxacillin, against Staphylococcus aureus and S. epidermidis].
Walencka E; Sadowska B; Wieckowska-Szakiel M; Rózalska B
Med Dosw Mikrobiol; 2008; 60(3):191-6. PubMed ID: 19143172
[TBL] [Abstract][Full Text] [Related]
53. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Noone P
Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
55. [Addition of gentamicine to polymethyl methacrylate for therapy of infectious bone diseases. Expeimental in vivo tests].
Koschmieder R; Ritzerfield W; Homeyer L
Z Orthop Ihre Grenzgeb; 1975 Feb; 113(1):147-9. PubMed ID: 239496
[TBL] [Abstract][Full Text] [Related]
56. Effect of combination therapy of rifampicin and azithromycin on TNF levels during a rat model of chronic osteomyelitis.
Littlewood-Evans AJ; Hattenberger M; Zak O; O'Reilly T
J Antimicrob Chemother; 1997 Apr; 39(4):493-8. PubMed ID: 9145822
[TBL] [Abstract][Full Text] [Related]
57. Combination of Erythromycin and Curcumin Alleviates
Zhou Z; Pan C; Lu Y; Gao Y; Liu W; Yin P; Yu X
Front Cell Infect Microbiol; 2017; 7():379. PubMed ID: 28884090
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of severe febrile neutropenia (author's transl)].
Meuret G; Roux A; Heim ME; Westerhausen M
Dtsch Med Wochenschr; 1980 Dec; 105(51):1776-9. PubMed ID: 6449360
[TBL] [Abstract][Full Text] [Related]
59. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
60. [Clinical, bacteriological and pharmacokinetic study of Sisomicin in the newborn infant].
Sorin M; de Merleire F; Berche P; Daoulas-Lebourdelles F; Veron M
Sem Hop; 1978 Mar; 54(5-8):345-50. PubMed ID: 211630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
